title: Model-Based Recursive Partitioning for Subgroup Analyses.
abstract: The identification of patient subgroups with differential treatment effects is the first step towards individualised treatments. A current draft guideline by the EMA discusses potentials and problems in subgroup analyses and formulated challenges to the development of appropriate statistical procedures for the data-driven identification of patient subgroups. We introduce model-based recursive partitioning as a procedure for the automated detection of patient subgroups that are identifiable by predictive factors. The method starts with a model for the overall treatment effect as defined for the primary analysis in the study protocol and uses measures for detecting parameter instabilities in this treatment effect. The procedure produces a segmented model with differential treatment parameters corresponding to each patient subgroup. The subgroups are linked to predictive factors by means of a decision tree. The method is applied to the search for subgroups of patients suffering from amyotrophic lateral sclerosis that differ with respect to their Riluzole treatment effect, the only currently approved drug for this disease.
authors.forename: Heidi
authors.initials: H
authors.lastname: Seibold
authors.forename: Achim
authors.initials: A
authors.lastname: Zeileis
authors.forename: Torsten
authors.initials: T
authors.lastname: Hothorn
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy; D003627:Data Interpretation, Statistical; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology; D017063:Outcome Assessment, Health Care / Q000379:methods*; D057285:Precision Medicine / Q000379:methods*; D012107:Research Design / Q000592:standards*; D019782:Riluzole / Q000494:pharmacology
chemical_list: D018696:Neuroprotective Agents; D019782:Riluzole